Fully funded by 
Content independently selected
Data on efficacy and tolerability of savolitinib for treatment of metastatic MET-driven papillary renal cell cancer
Proposed changes improve survival discrimination by stage vs current AJCC system.
Results of a meta-analysis.
Results of a meta-analysis involving 857K participants.
High-level accuracy in testing for disease-specific mutations.
For the small number of men with localized recurrence, HIFU has the potential to be curative.
Virtually all high-grade disease occurred in the 43.1% of women who were HPV positive.
Dark hair dyes, relaxers in particular linked to increased risk.
Switching shows benefit in men with nonresponse to 12 wks of docetaxel or cabazitaxel.
Most prior studies focused on low-risk patients.
Study carried out in women aged 50 y or younger with prior breast conservation therapy.
Meaningful responses in heavily pretreated patients.
No difference for bevacizumab vs cetuximab in advanced/metastatic CRC.
The portal will serve as a single portal for licence applications and a public source of information on all clinical trials conducted in the EU.
BMI does not appear to affect development of radiation therapy-related toxicities.
